Skip to main content
Skip to main content
DRFS logo

Dr. Foods, Inc. (DRFS)

$0.04 +$0.00 (+0.00%) |CouncilHOLD · 43 · C
Signals are mixed — the Council read leans HOLD (43/100) while the AI fundamental score is 63/100 (grade B+); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Seth Klarman bearish.
MCap: $3.93M|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Dr. Foods, Inc. (DRFS) trades at $0.04 with AI Score 63/100 (Grade B+). Dr. Foods, Inc. is a Tokyo-based company, incorporated in 2021, engaged in the import, resale, development, and manufacturing of various food products. Market cap: $3.93M, Sector: Industrials.

Price live · AI analysis from Jun 15, 2026
Dr. Foods, Inc. is a Tokyo-based company, incorporated in 2021, engaged in the import, resale, development, and manufacturing of various food products. Despite its official classification under the Industrials sector, its core operations are within the food and beverage industry.

Analyst Coverage for DRFS: DRFS does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates DRFS against Industrials peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Council Score · Weighted Average of 3 Disciplines
HOLD 43/100 · C

DRFS: the 4 perspectives are evenly split. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Neutral
Council Score · 8 perspectives · See tabs for details →

Dr. Foods, Inc. (DRFS) Industrial Operations Profile

CEOKoichi Ishizuka
Employees1
HeadquartersTokyo, JP
IPO Year2008

Dr. Foods, Inc. is a Tokyo-based entity, established in 2021, specializing in the import, resale, development, and manufacturing of diverse food products. Operating with a unique business model, the company navigates the competitive food and beverage sector while formally categorized within the Industrials industry, focusing on product innovation and market penetration.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 15, 2026

What Is the Investment Thesis for DRFS?

Dr. Foods, Inc. presents an investment profile characterized by its nascent stage and operational focus within the food products sector, despite its formal classification under Industrials. The company's business model, encompassing import, resale, development, and manufacturing of food products, positions it to capitalize on increasing consumer demand for innovative food items. Key value drivers include its 100.0% gross margin, indicating strong pricing power or efficient direct costs on its current sales, and its agility as a small, focused entity. However, the company faces significant challenges, notably a -4785.1% profit margin and a $3.93M market capitalization, signaling substantial operational costs relative to revenue and a very early stage of market development. As an OTC Other listed stock, DRFS carries inherent risks such as lower liquidity, less stringent disclosure requirements, and potential price volatility. The ability to transition from high gross margin to sustainable profitability through effective cost management and scaling of operations will be a critical catalyst for future valuation. Investors must closely monitor the company's strategic execution in product development and market penetration within the competitive food industry, alongside its efforts to improve financial performance.

Based on FMP financials and quantitative analysis

DRFS Key Highlights

  • Dr. Foods, Inc. maintains a 100.0% gross margin, indicating strong direct cost control or pricing power on its current revenue streams.
  • The company reported a significant negative profit margin of -4785.1%, highlighting substantial operational expenses relative to its revenue.
  • Dr. Foods, Inc. currently has a market capitalization of $3.93M, reflecting its very early stage of public market development.
  • The company operates with a lean structure, employing a single individual, which may offer agility but also presents scalability challenges.
  • Incorporated in 2021 and based in Tokyo, Japan, Dr. Foods, Inc. is a relatively new entrant in the food products market.

Who Are DRFS's Competitors?

DRFS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BCHTD Birchtech Corp. $3.49 +1.16% $67.90M 65
ACTHF Aduro Clean Technologies Inc. $5.45 +0.00% $148.38M 61
MTWTF METAWATER Co., Ltd. $22.88 +0.00% $1.00B 56
EMFGF Fluence Corporation Limited $0.05 +0.00% $57.65M 56
CECO CECO Environmental Corp. $80.68 -1.79% $2.89B 55
ZONE ZONE $0.85 +16.00% $187.98M 55
CLIR ClearSign Technologies Corporation $4.00 -1.50% $24.76M 54
ZWS Zurn Elkay Water Solutions Corporation $49.31 +0.32% $8.26B 54

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are DRFS's Key Strengths?

  • Exceptional 100.0% gross margin, indicating strong pricing power or efficient direct cost management.
  • Agility and flexibility afforded by a lean operational structure with one employee.
  • Diverse business model encompassing import, resale, development, and manufacturing of food products.
  • Potential for innovative product development to meet evolving consumer demands.

What Are DRFS's Weaknesses?

  • Significantly negative profit margin of -4785.1%, indicating high operational costs relative to revenue.
  • Extremely small market capitalization of $3.93M, reflecting a very early stage or limited market presence.
  • Reliance on a single employee, posing scalability and operational continuity risks.
  • Unknown disclosure status and OTC Other listing, leading to limited transparency and liquidity.

What Could Drive DRFS Stock Higher?

  • Introduction of new, innovative food products that gain traction in the Japanese market, potentially boosting revenue streams.
  • Efforts to achieve sustainable profitability through strategic cost management and scaling of operations, which could improve the negative profit margin.
  • Formation of strategic partnerships for enhanced distribution or co-development, expanding market reach and operational capabilities.
  • Development of a robust e-commerce presence to directly access consumers and improve sales efficiency.

What Are the Key Risks for DRFS?

  • Negative return on equity (-4.1%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Persistent negative profit margin of -4785.1%, indicating that current operational costs significantly outweigh revenues, posing a threat to long-term viability.
  • Intense competition within the food and beverage industry, requiring continuous innovation and effective market differentiation.
  • Inability to scale operations or manage costs effectively, preventing the company from achieving sustainable profitability.
  • Risks associated with trading on the OTC Other market, including extremely low liquidity, lack of transparency, and potential for price volatility.
  • Reliance on a single employee for all operations, which could lead to significant challenges in scalability, succession, and operational continuity.

What Are the Growth Opportunities for DRFS?

  • **Expansion into Niche Food Markets:** Dr. Foods, Inc. could significantly grow by targeting specific, high-growth niche food markets such as functional foods, plant-based alternatives, or gourmet specialty products. The global functional food market, for instance, is projected to reach substantial valuations, driven by increasing health consciousness. By developing or importing unique products tailored to these segments, Dr. Foods, Inc. could command premium pricing and cultivate a loyal customer base. This strategy would leverage its development and manufacturing capabilities to create differentiated offerings, providing a competitive edge against larger, more generalized food companies. A focused approach could yield higher margins and stronger brand recognition within these specialized areas over the next 3-5 years.
  • **Leveraging E-commerce and Direct-to-Consumer (DTC) Channels:** Establishing robust e-commerce platforms and a direct-to-consumer sales model presents a significant growth avenue. The global e-commerce food and beverage market has experienced rapid expansion, offering companies direct access to consumers without reliance on traditional retail intermediaries. For Dr. Foods, Inc., this could mean reduced distribution costs, greater control over branding and customer experience, and the ability to gather direct consumer feedback for product iteration. Investing in digital marketing and logistics for DTC sales could unlock substantial market reach and revenue growth, particularly in urban centers and for specialty products, with potential impact within 2-4 years.
  • **Strategic Partnerships and Collaborations:** Forming strategic alliances with established retailers, food service providers, or even other food technology companies could accelerate market penetration and product distribution. Collaborations might involve co-development of new products, exclusive supply agreements, or leveraging existing distribution networks. For a company with a lean operational structure like Dr. Foods, Inc., such partnerships can provide access to resources, expertise, and market channels that would be costly and time-consuming to build independently. These alliances could significantly expand the company's footprint and product visibility within 1-3 years, especially in the competitive Japanese market.
  • **Product Innovation and Portfolio Diversification:** Continuous innovation in product development, including exploring new ingredients, processing techniques, or packaging solutions, can drive sustained growth. Diversifying its product portfolio beyond current offerings to include categories with high consumer demand, such as sustainable or ethically sourced foods, could attract a broader customer base. The market for sustainable food products is growing consistently, indicating a strong consumer preference. By investing in R&D and market research, Dr. Foods, Inc. can stay ahead of trends, introduce novel products, and maintain relevance in a fast-evolving industry, with new product cycles typically spanning 1-2 years.
  • **Optimizing Supply Chain and Operational Efficiency:** Given the company's 100.0% gross margin but significantly negative profit margin, a critical growth opportunity lies in optimizing its supply chain and overall operational efficiency. This could involve negotiating better terms with suppliers, streamlining manufacturing processes, or implementing advanced inventory management systems to reduce waste and overheads. Improving efficiency directly impacts the bottom line, converting high gross margins into sustainable profitability. Even small improvements in operational costs can have a substantial effect on net income, allowing for reinvestment into growth initiatives. This internal optimization effort is an ongoing opportunity with continuous benefits.

What Opportunities Does DRFS Have?

  • Increasing consumer demand for innovative, specialty, and health-conscious food products.
  • Expansion into new product categories or niche markets within the food sector.
  • Leveraging e-commerce channels for direct-to-consumer sales and broader market reach.
  • Strategic partnerships to enhance distribution, manufacturing capabilities, or product innovation.

What Threats Does DRFS Face?

  • Intense competition within the global and local food and beverage industry.
  • Challenges in achieving sustainable profitability due to high operational costs.
  • Regulatory changes in food safety, import/export, and labeling.
  • Risks associated with OTC Other listing, including low liquidity and potential for price volatility.

What Are DRFS's Competitive Advantages?

  • Potential for proprietary food product development and manufacturing expertise.
  • Agility and lean operational structure allowing for quick adaptation to market trends.
  • Established network for importing diverse food products.
  • Direct control over product quality and innovation through integrated business functions.

What Does DRFS Do?

Dr. Foods, Inc., established in Tokyo, Japan, in 2021, operates as a multifaceted entity within the food products sector, despite its formal classification under the Industrials sector. The company's core business model encompasses the import, resale, development, and manufacturing of a variety of food products, aiming to cater to evolving consumer demands. From its inception, Dr. Foods, Inc. has focused on establishing a presence in the Japanese food market by leveraging a flexible approach to product sourcing and creation. Its activities span the entire value chain, from identifying and importing suitable food items to developing proprietary products and overseeing their manufacturing processes. This integrated approach allows the company to maintain control over product quality and innovation. While specific product lines are not detailed, the company's mandate to handle 'various food products' suggests a broad portfolio that could range from specialty ingredients to ready-to-eat meals or health-focused consumables. The company's operational base in Tokyo positions it within a vibrant and competitive market, necessitating a keen understanding of local consumer preferences and supply chain dynamics. With a lean operational structure, evidenced by its single employee, Dr. Foods, Inc. likely emphasizes agility and strategic partnerships to execute its diverse business functions across the food industry landscape.

What Products and Services Does DRFS Offer?

  • Imports various food products from international markets.
  • Resells a diverse range of food items to consumers or businesses.
  • Develops new food products, potentially involving research and formulation.
  • Manufactures its own line of food products, overseeing production processes.
  • Operates within the food and beverage sector, despite its official 'Industrials' classification.
  • Based in Tokyo, Japan, serving the domestic market and potentially beyond.

How Does DRFS Make Money?

  • Generates revenue through the sale of imported and resold food products.
  • Earns income from the sale of proprietary food products developed and manufactured in-house.
  • Focuses on a multi-faceted approach encompassing sourcing, development, and distribution within the food supply chain.
  • Aims to capitalize on consumer demand for innovative and diverse food items.

What Industry Does DRFS Operate In?

Dr. Foods, Inc. operates within the highly dynamic and competitive food and beverage sector, despite its official categorization under the 'Industrials - Pollution & Treatment Controls' industry. This classification discrepancy suggests a unique or evolving business structure, but its core activities of importing, reselling, developing, and manufacturing food products firmly place it within the consumer staples landscape. The broader food industry is characterized by increasing consumer demand for innovative, healthy, and convenient food products, a trend that Dr. Foods, Inc. is potentially positioned to address. The competitive landscape includes a wide array of players, from large multinational corporations to niche startups, all vying for market share through product differentiation, brand loyalty, and efficient supply chains. Dr. Foods, Inc.'s success will depend on its ability to carve out a distinct market position, manage its operational costs effectively, and scale its product offerings to meet market demands amidst intense competition and evolving consumer preferences in Japan and potentially beyond.

Who Are DRFS's Key Customers?

  • Individual consumers seeking diverse and innovative food products.
  • Retailers, including supermarkets, specialty food stores, and online platforms.
  • Food service establishments such as restaurants or cafes.
  • Distributors who further disseminate products to various points of sale.
AI Confidence: 62% Updated: Jun 15, 2026

How Dr. Foods, Inc. Is Valued

Dr. Foods, Inc. carries a market capitalization of $3.93M, placing it in the micro-cap category. Relative to its peer group, DRFS's quantitative score of 63/100 is roughly in line with the peer average of 59/100.

Company Profile

Dr. Foods, Inc. operates in the Industrial - Pollution & Treatment Controls industry within the Industrials sector. It is headquartered in Tokyo, JP. The company is led by CEO Koichi Ishizuka. DRFS has traded publicly since 2008.

ROE -4%Key Financial Metrics

Return on equity for Dr. Foods, Inc. stands at -4.1%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -1.6%, showing how much profit it generates from its asset base. Its free cash flow yield is 0.1%, a gauge of the cash the business throws off relative to its market value. A current ratio of 6.58 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -0.7%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 3/9Financial Health

Dr. Foods, Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.

DRFS Financials

Fundamental Snapshot

Net Income Growth (FY)
-136.7%
EPS Growth (FY)
-124.0%
Free Cash Flow Growth (FY)
+12.5%
Return on Equity (TTM)
-4.1%
Current Ratio
6.6

Based on FMP financials and quantitative analysis · FY 2024

Bull Case vs Bear Case

Bull Case

  • Exceptional 100.0% gross margin, indicating strong pricing power or efficient direct cost management.
  • Agility and flexibility afforded by a lean operational structure with one employee.
  • Diverse business model encompassing import, resale, development, and manufacturing of food products.
  • Potential for innovative product development to meet evolving consumer demands.

Bear Case

  • Significantly negative profit margin of -4785.1%, indicating high operational costs relative to revenue.
  • Extremely small market capitalization of $3.93M, reflecting a very early stage or limited market presence.
  • Reliance on a single employee, posing scalability and operational continuity risks.
  • Unknown disclosure status and OTC Other listing, leading to limited transparency and liquidity.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026

DRFS Latest News

No recent news available for DRFS.

DRFS Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for DRFS.

Price Targets

Wall Street price target analysis for DRFS.

DRFS MoonshotScore

63/100

What does this score mean?

The MoonshotScore rates DRFS's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Leadership: Koichi Ishizuka

CEO

Unknown

Track Record: Unknown

DRFS OTC Market Information

Dr. Foods, Inc. trades on the OTC Other tier, which represents the lowest and most speculative segment of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent financial and governance standards, OTC Other companies have minimal to no public disclosure requirements. This tier is typically for companies that are distressed, defunct, or have not provided current information to OTC Markets Group. Investors should understand that this tier offers significantly less transparency and regulatory oversight compared to higher OTC tiers like OTCQX or OTCQB, let alone national exchanges, making comprehensive due diligence challenging.

  • OTC Tier: OTC Other
  • Disclosure Status: Unknown
Liquidity: Given Dr. Foods, Inc.'s $3.93M market capitalization and OTC Other listing, liquidity is expected to be extremely low. Trading volume is likely minimal, leading to wide bid-ask spreads and significant price volatility. Investors may find it difficult to buy or sell shares without substantially impacting the stock price, and there is a high risk of being unable to liquidate positions quickly or at a desired price. The illiquidity inherent in OTC Other stocks often deters institutional investors and contributes to their speculative nature.
OTC Risk Factors:
  • Lack of public financial disclosure, making fundamental analysis nearly impossible.
  • Extremely low trading volume and wide bid-ask spreads, leading to significant liquidity risk.
  • High susceptibility to price manipulation due to limited oversight and low float.
  • Difficulty in obtaining reliable information about the company's operations, assets, and liabilities.
  • Limited or no analyst coverage, leaving investors without independent research and valuation.
Due Diligence Checklist:
  • Verify the company's legal existence and registration status with relevant authorities.
  • Attempt to locate any available financial statements or business updates, however informal.
  • Research the background and legitimacy of the management team, if information is available.
  • Assess the actual operational status and tangible assets of the business.
  • Understand the share structure and any potential dilution risks.
  • Consult with legal and financial advisors experienced in OTC markets.
Legitimacy Signals:
  • Consistent, albeit minimal, communication from the company regarding its operations.
  • Evidence of actual business activities, such as product development or sales, even if small scale.
  • Any verifiable physical presence or operational infrastructure in Tokyo.
  • Retention of an independent auditor or legal counsel, even if not publicly disclosed.
  • A clear and consistent business description that aligns with any observable activities.

What Investors Ask About Dr. Foods, Inc. (DRFS) — Industrials

What does Dr. Foods, Inc. do?

Dr. Foods, Inc. is a Tokyo-based company established in 2021 that operates across multiple facets of the food products sector. Its business model is comprehensive, encompassing the import of various food items from international sources, the resale of these and other food products, and the in-house development and manufacturing of its own proprietary food offerings. This integrated approach allows Dr. Foods, Inc. to control the entire value chain from sourcing to production and distribution. The company aims to cater to consumer demand for diverse and innovative food products within the competitive Japanese market, leveraging its lean structure for agility in product selection and market response.

How does Dr. Foods, Inc.'s operational focus on food products align with its official 'Industrials' sector classification?

Dr. Foods, Inc.'s official classification under the 'Industrials - Pollution & Treatment Controls' sector presents a notable discrepancy with its stated business operations, which are firmly rooted in the food and beverage sector. While the company's core activities involve importing, reselling, developing, and manufacturing food products, its sector categorization suggests either a unique historical classification, a diversified business segment not detailed in public information, or a potential misclassification within public databases. For investors, it is crucial to prioritize the company's explicit business description and operational focus on food products when assessing its market position, competitive landscape, and growth opportunities, rather than relying solely on the broad sector label.

What are the primary financial challenges facing Dr. Foods, Inc., and how might they impact its future?

Dr. Foods, Inc. faces significant financial challenges, most notably its -4785.1% profit margin and a $3.93M market capitalization. While the company boasts a 100.0% gross margin, indicating strong control over direct production costs or effective pricing, the deeply negative profit margin suggests that its operational expenses (e.g., administrative, marketing, R&D) are substantially higher than its revenue. This imbalance poses a critical threat to its long-term viability and ability to fund growth initiatives. Without a clear path to sustainable profitability, the company may struggle to attract further investment, scale its operations, or withstand competitive pressures, potentially limiting its future expansion and product development efforts within the food industry.

What are the specific risks associated with Dr. Foods, Inc.'s listing on the OTC Other market?

Dr. Foods, Inc.'s listing on the OTC Other market carries several specific and elevated risks for investors. This tier is characterized by minimal to no public disclosure requirements, resulting in a severe lack of transparent financial and operational information. This makes comprehensive due diligence extremely difficult. Furthermore, OTC Other stocks typically suffer from extremely low liquidity, meaning there may be few buyers or sellers, leading to wide bid-ask spreads and significant price volatility. Investors might struggle to execute trades efficiently or liquidate positions without impacting the stock price. The absence of stringent regulatory oversight also increases the potential for market manipulation and makes it challenging to ascertain the true value or legitimacy of the company's operations.

What are the key factors to evaluate for DRFS?

Dr. Foods, Inc. (DRFS) holds an AI score of 63/100 (moderate). Not financial advice.

How frequently does DRFS data refresh on this page?

DRFS prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.

What has driven DRFS's recent stock price performance?

Dr. Foods, Inc. (DRFS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Exceptional 100.0% gross margin, indicating strong pricing power or efficient direct cost management. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider DRFS overvalued or undervalued right now?

Valuing Dr. Foods, Inc. (DRFS) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is limited, particularly regarding detailed financials beyond key margins, specific product lines, and the CEO's background and track record.
  • There is a notable discrepancy between the company's official 'Industrials - Pollution & Treatment Controls' sector classification and its stated business operations in the food products sector. The analysis prioritizes the business description for narrative sections.
  • The extremely low market capitalization ($0.00B) and negative profit margin (-4785.1%) indicate a very early-stage company with significant operational challenges.
Data Sources

Popular Stocks